Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul Buderath
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Role of Soluble Programmed Death-1 (sPD-1) and sPD-ligand 1 in Patients With Cystic Echinococcosis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors
Asian Pacific Journal of Cancer Prevention
Induction of FGF Receptor 2-IIIb Expression and Response to Its Ligands in Epithelial Ovarian Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
Frontiers in Oncology
Cancer Research
Oncology
Soluble VEGF Receptor 1 (sFLT1) Induces Non-Apoptotic Death in Ovarian and Colorectal Cancer Cells
Scientific Reports
Multidisciplinary
Der Aufbruch Der Frauen in Der SPD
The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort
Oncotarget
Oncology
Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy
Respiratory Research
Pulmonary
Respiratory Medicine
Engineering Interface Structures and Thermal Stabilities via SPD Processing in Bulk Nanostructured Metals
Scientific Reports
Multidisciplinary
